Prognostic Significance of C-Reactive Protein in Lenvatinib-Treated Unresectable Hepatocellular Carcinoma: A Multi-Institutional Study

SIMPLE SUMMARY: Serum C-reactive protein (CRP) is an established biomarker for acute inflammation and has been identified as a prognostic indicator for hepatocellular carcinoma (HCC). It is especially important to verify the utility of CRP in HCC patients treated with lenvatinib because the benefits...

Descripción completa

Detalles Bibliográficos
Autores principales: Okumura, Taiki, Kimura, Takefumi, Iwadare, Takanobu, Wakabayashi, Shun-ichi, Kobayashi, Hiroyuki, Yamashita, Yuki, Sugiura, Ayumi, Joshita, Satoru, Fujimori, Naoyuki, Kunimoto, Hideo, Komatsu, Michiharu, Fukushima, Hideki, Mori, Hiromitsu, Umemura, Takeji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10670047/
https://www.ncbi.nlm.nih.gov/pubmed/38001602
http://dx.doi.org/10.3390/cancers15225343

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10670047/
https://www.ncbi.nlm.nih.gov/pubmed/38001602
http://dx.doi.org/10.3390/cancers15225343

Ejemplares similares